Clovis Oncology Announces Rubraca®▼ (rucaparib) Now Available for Women with Relapsed Ovarian Cancer in England Through the Cancer Drugs Fund

Many women with relapsed ovarian cancer know that they are facing a future of managing their disease as a chronic illness.